About
About Tibet Weixinkang Medicine Co., Ltd
Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China. It offers APIs; multivitamins and pediatric multivitamins for injections; concentrate of trace elements solution for infusion; compound and pediatric compound amino acid injections; iron sucrose, multiple electrolytes, potassium aspartate and magnesium aspartate, carbohydrate and electrolyte, pentoxifylline, piracetam, and dopamine hydrochloride injections; and acetylcysteine solution for inhalation. The company was formerly known as Weixinkang Medicine Youxian Gongsi and changed its name to Tibet Weixinkang Medicine Co., Ltd. in 2015. Tibet Weixinkang Medicine Co., Ltd. was founded in 2002 and is based in Lhasa, China.
Visit company website
5 years, 5 months ago
Tibet Weixinkang Medicine Co., Ltd is currently in a long term downtrend where the price is trading 10.4% below its 200 day moving average.
From a valuation standpoint, the stock is 49.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.9.
Tibet Weixinkang Medicine Co., Ltd's total revenue sank by 8.1% to $185M since the same quarter in the previous year.
Its net income has increased by 130.2% to $16M since the same quarter in the previous year.
Finally, its free cash flow grew by 412.8% to $36M since the same quarter in the previous year.
Based on the above factors, Tibet Weixinkang Medicine Co., Ltd gets an overall score of 3/5.